logo-large
  • Browse Categories

Publications by authors named "Eva K Roth"

Claim this Profile
S
Systematic analysis of RNA-binding proteins identifies targetable therapeutic vulnerabilities in osteosarcoma.
Yang Zhou, Partho Sarothi Ray, Jianguo Zhu, Frank Stein, Mandy Rettel, Eva K Roth

Nat Commun· April 2024


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prexasertib (LY2606368) reduces clonogenic survival by inducing apoptosis in primary patient-derived osteosarcoma cells and synergizes with cisplatin and talazoparib.
Christopher L Heidler, Eva K Roth, Markus Thiemann, Claudia Blattmann, Ramon L Perez

Int J Cancer· August 2020


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment of a patient-derived orthotopic osteosarcoma mouse model.
Claudia Blattmann, Markus Thiemann, Albrecht Stenzinger, Eva K Roth, Anne Dittmar

J Transl Med· April 2015


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The K+ channel opener 1-EBIO potentiates residual function of mutant CFTR in rectal biopsies from cystic fibrosis patients.
Eva K Roth, Stephanie Hirtz, Julia Duerr, Daniel Wenning, Irmgard Eichler

PLoS One· January 2012


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: